These two features of SLC7A11, its non-essential nature in normal physiology and its high expression in cancer, suggest that targeting SLC7A11 may selectively kill tumor cells and impair tumor growth while preserving normal cells or tissues. This evidence concerns the gene SLC7A11 and cancer.